Stock Events

Alphatec 

€5.1
21
+€0+0% Hoy

Estadísticas

Día Alto
5.1
Día de baja
5.1
52W Alto
-
52W Bajo
-
Volumen
0
Volumen medio
-
Cap. de mercado
708.78M
Relación P/U
-
Rentabilidad por dividendo
-
Dividendo
-

Próximamente

Ganancias

31OctEsperado
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Siguiente
-0.17
-0.13
-0.1
-0.07
GPA esperado
-0.096005375
GPA actual
No aplica

La gente también sigue a

Esta lista se basa en las watchlists de personas que siguen a L1Z1.F en Stock Events. Esto no es una recomendación de inversión.

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.

Acerca de

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Show more...
Director general
Mr. Patrick S. Miles
Empleados
839
País
US
ISIN
US02081G2012
WKN
000A2AP5V

Listados